What does Société Médicale Dr VAN DURME do?

Société Médicale Dr VAN DURME is a research organisation in Liège. Private Limited, started on 29 May 2015, 1 establishment.

What is the address of Société Médicale Dr VAN DURME?

The registered office of Société Médicale Dr VAN DURME is located at Rue Jacob-Makoy 48, 4000 Liège.

Is Société Médicale Dr VAN DURME still active?

Yes. According to the CBE (3 October 2026) Société Médicale Dr VAN DURME is active, legal situation “Normale toestand”, started on 29 May 2015.

Is Société Médicale Dr VAN DURME registered on Peppol?

Yes, Société Médicale Dr VAN DURME is registered on the Peppol network with ID 0208:0630945309.

What is the enterprise number of Société Médicale Dr VAN DURME?

The enterprise number of Société Médicale Dr VAN DURME is BE0630945309.

When was Société Médicale Dr VAN DURME founded?

Société Médicale Dr VAN DURME was founded on 29 May 2015.

Who are the directors of Société Médicale Dr VAN DURME?

According to the 2025 annual accounts, the directors of Société Médicale Dr VAN DURME are: Caroline Van Durme.

Is Société Médicale Dr VAN DURME a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 29 May 2015; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Société Médicale Dr VAN DURME make in 2025?

Société Médicale Dr VAN DURME posted a profit after taxes of € 10,694 in financial year 2025.

What is the revenue of Société Médicale Dr VAN DURME?

As a small company, Société Médicale Dr VAN DURME is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 35,012.

Société Médicale Dr VAN DURME (Private Limited) - Liège

Dossier Société Médicale Dr VAN DURME, printed on 3 October 2026 from databakkes.be/en/0630945309/societe-medicale-dr-van-durme. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Société Médicale Dr VAN DURME from Liège, company number BE0630945309, closed financial year 2025 with a result of € 10,694 after tax. For that financial year Société Médicale Dr VAN DURME recorded a gross margin of € 35,012 and equity of € 93,341. Compared with financial year 2024, the result moved from € 23,402 to € 10,694. The company is profitable. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 27, 2026.

What it is worth Healthy

€ 93,341

▼ 14% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 10,694

▼ 54% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 31,081

▼ 29% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 26,186 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 3,950

▼ 13% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 974

▲ € 756 vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 2,682

▲ 174% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 46,561 Gross margin 2022: € 46,561 First fiscal year in the series	€ 62,432 Gross margin 2023: € 62,432 ▲ 34% vs 2022 (€ 46,561) Favourable step	€ 47,181 Gross margin 2024: € 47,181 ▼ 24% vs 2023 (€ 62,432) Unfavourable step	€ 35,012 Gross margin 2025: € 35,012 ▼ 26% vs 2024 (€ 47,181) Unfavourable step	▼ 26%
Profit after taxes	€ 26,186 Profit after taxes 2022: € 26,186 First fiscal year in the series	€ 40,646 Profit after taxes 2023: € 40,646 ▲ 55% vs 2022 (€ 26,186) Favourable step	€ 23,402 Profit after taxes 2024: € 23,402 ▼ 42% vs 2023 (€ 40,646) Unfavourable step	€ 10,694 Profit after taxes 2025: € 10,694 ▼ 54% vs 2024 (€ 23,402) Unfavourable step	▼ 54%
Equity	€ 55,075 Equity 2022: € 55,075 First fiscal year in the series	€ 95,722 Equity 2023: € 95,722 ▲ 74% vs 2022 (€ 55,075) Favourable step	€ 108,833 Equity 2024: € 108,833 ▲ 14% vs 2023 (€ 95,722) Favourable step	€ 93,341 Equity 2025: € 93,341 ▼ 14% vs 2024 (€ 108,833) Unfavourable step	▼ 14%
Total debts	€ 0 Total debts 2022: € 0 First fiscal year in the series	€ 4,064 Total debts 2023: € 4,064 Unchanged (€ 0) Unfavourable step	€ 1,197 Total debts 2024: € 1,197 ▼ 71% vs 2023 (€ 4,064) Favourable step	€ 28,440 Total debts 2025: € 28,440 ▲ € 27,242 vs 2024 (€ 1,197) Unfavourable step	▲ € 27,242
Cash	€ 27,915 Cash 2022: € 27,915 First fiscal year in the series	€ 61,685 Cash 2023: € 61,685 ▲ 121% vs 2022 (€ 27,915) Favourable step	€ 43,873 Cash 2024: € 43,873 ▼ 29% vs 2023 (€ 61,685) Unfavourable step	€ 31,081 Cash 2025: € 31,081 ▼ 29% vs 2024 (€ 43,873) Unfavourable step	▼ 29%
Land & buildings	-	-	-	€ 8,715 Land & buildings 2025: € 8,715 First fiscal year in the series
Retained profit	€ 36,475 Retained profit 2022: € 36,475 First fiscal year in the series	€ 77,122 Retained profit 2023: € 77,122 ▲ 111% vs 2022 (€ 36,475) Favourable step	€ 90,233 Retained profit 2024: € 90,233 ▲ 17% vs 2023 (€ 77,122) Favourable step	€ 74,741 Retained profit 2025: € 74,741 ▼ 17% vs 2024 (€ 90,233) Unfavourable step	▼ 17%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 10,290 Dividend 2024: € 10,290 Unchanged (€ 0) Unchanged	€ 26,186 Dividend 2025: € 26,186 ▲ 154% vs 2024 (€ 10,290) Unchanged	▲ 154%
Balance sheet total	€ 55,075 Balance sheet total 2022: € 55,075 First fiscal year in the series	€ 99,786 Balance sheet total 2023: € 99,786 ▲ 81% vs 2022 (€ 55,075) Unchanged	€ 110,031 Balance sheet total 2024: € 110,031 ▲ 10% vs 2023 (€ 99,786) Unchanged	€ 121,781 Balance sheet total 2025: € 121,781 ▲ 11% vs 2024 (€ 110,031) Unchanged	▲ 11%

Key figures of Société Médicale Dr VAN DURME, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Société Médicale Dr VAN DURME?

What happened at Société Médicale Dr VAN DURME in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 27, 2026 New annual accounts for financial year 2025: profit of € 10,694 (▼ 54% vs 2024). filed late Source: NBB ↗
May 29, 2015 New establishment in Liège. KBO
May 29, 2015 Start of the company according to the CBE. KBO

In short

From € 26,186 profit in 2022 to € 10,694 profit in 2025.

Paid € 74,318 in corporate taxes since 2022.

Best year ever: 2023, with € 40,646 profit.

Paid out € 36,475 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at Société Médicale Dr VAN DURME? We notify you, reason included.

Follow Société Médicale Dr VAN DURME

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Caroline Van Durme

Société Médicale Dr VAN DURME

Behind Société Médicale Dr VAN DURME is Caroline Van Durme.

See the full network in the app

Directors

According to the 2025 annual accounts

Caroline Van Durme

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Rue Jacob-Makoy 48

4000 Liège

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0630.945.309

VAT number

BE 0630.945.309

Registered office

Rue Jacob-Makoy 48, 4000 Liège

Names & denominations

Société Médicale Dr VAN DURME

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

29 May 2015

Peppol

Active · Active since 23 Jan 2026

Activities · NACE

Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied

Overige vormen van onderwijs

View on CBE Public ↗ Annual accounts (NBB) ↗

Société Médicale Dr VAN DURME

Financials

What happened to Société Médicale Dr VAN DURME?

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Management

Directors

Establishments

Establishment units

Details

Frequently asked questions